FI953510A - Laskostuneita, tripleksiä muodostavia oligonukleotideja - Google Patents
Laskostuneita, tripleksiä muodostavia oligonukleotideja Download PDFInfo
- Publication number
- FI953510A FI953510A FI953510A FI953510A FI953510A FI 953510 A FI953510 A FI 953510A FI 953510 A FI953510 A FI 953510A FI 953510 A FI953510 A FI 953510A FI 953510 A FI953510 A FI 953510A
- Authority
- FI
- Finland
- Prior art keywords
- triplex
- folded
- forming oligonucleotides
- oligonucleotides
- forming
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C12N2310/152—Nucleic acids forming more than 2 strands, e.g. TFOs on a single-stranded target, e.g. fold-back TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3527—Other alkyl chain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US800093A | 1993-01-21 | 1993-01-21 | |
| PCT/US1994/000755 WO1994017091A2 (en) | 1993-01-21 | 1994-01-21 | Foldback triplex-forming oligonucleotides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI953510A0 FI953510A0 (fi) | 1995-07-20 |
| FI953510A true FI953510A (fi) | 1995-08-24 |
Family
ID=21729265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI953510A FI953510A (fi) | 1993-01-21 | 1995-07-20 | Laskostuneita, tripleksiä muodostavia oligonukleotideja |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5739308A (fi) |
| EP (1) | EP0680489A1 (fi) |
| JP (1) | JPH08505778A (fi) |
| KR (1) | KR960700263A (fi) |
| CN (1) | CN1122138A (fi) |
| AU (1) | AU684748B2 (fi) |
| CA (1) | CA2154358A1 (fi) |
| FI (1) | FI953510A (fi) |
| NZ (1) | NZ261976A (fi) |
| WO (1) | WO1994017091A2 (fi) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5741396A (en) * | 1995-05-11 | 1996-11-29 | Hybridon, Inc. | Pyrimidine targeting hairpin triplex-forming oligonucleotide s |
| US6117993A (en) * | 1995-05-23 | 2000-09-12 | Hybridon, Inc. | Synthons for oligonucleotide synthesis |
| US5750674A (en) * | 1995-05-23 | 1998-05-12 | Hybridon, Inc. | Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced |
| US5693773A (en) * | 1995-06-07 | 1997-12-02 | Hybridon Incorporated | Triplex-forming antisense oligonucleotides having abasic linkers targeting nucleic acids comprising mixed sequences of purines and pyrimidines |
| US6274313B1 (en) | 1996-03-21 | 2001-08-14 | Pioneer-Hybrid International, Inc. | Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use |
| US6331617B1 (en) | 1996-03-21 | 2001-12-18 | University Of Iowa Research Foundation | Positively charged oligonucleotides as regulators of gene expression |
| US6776986B1 (en) | 1996-06-06 | 2004-08-17 | Novartis Ag | Inhibition of HIV-1 replication by antisense RNA expression |
| US5886165A (en) * | 1996-09-24 | 1999-03-23 | Hybridon, Inc. | Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments |
| IL121312A (en) * | 1997-07-14 | 2001-09-13 | Technion Res & Dev Foundation | Microelectronic components, their manufacture and electronic networks containing them |
| CN1057302C (zh) * | 1997-08-27 | 2000-10-11 | 中国科学院上海生物化学研究所 | 抑制乙型肝炎病毒复制的反义脱氧寡核苷酸 |
| CN1215058A (zh) | 1997-10-21 | 1999-04-28 | 中国科学院上海生物化学研究所 | 新的三链形成寡核苷酸结构及其在抗乙肝病毒中的应用 |
| US20030203394A1 (en) * | 1998-05-04 | 2003-10-30 | Yoav Eichen | Detection of a target in a sample |
| IL126776A (en) | 1998-10-27 | 2001-04-30 | Technion Res & Dev Foundation | A method of investing gold |
| CN1091111C (zh) * | 1998-11-09 | 2002-09-18 | 中国人民解放军军事医学科学院放射医学研究所 | 治疗丙型肝炎病毒相关性疾病的反义寡核苷酸的结构与用途 |
| EP1196629A2 (en) | 1999-04-07 | 2002-04-17 | Dennis Michael Connolly | High resolution dna detection methods and devices |
| ATE421999T1 (de) | 1999-07-09 | 2009-02-15 | Gen Probe Inc | Nachweis von hiv-1 durch amplifizierung von nukleinsäuren |
| US7364920B2 (en) * | 1999-10-27 | 2008-04-29 | Technion Research And Development Foundation Ltd. | Method for gold deposition |
| AU1354201A (en) * | 1999-10-29 | 2001-05-14 | Cygene, Inc. | Compositions and methods of synthesis and use of novel nucleic acid structures |
| JP2002125687A (ja) * | 2000-10-30 | 2002-05-08 | Tosoh Corp | Ｈｉｖ−１検出のためのオリゴヌクレオチドおよび検出法 |
| US20050288242A1 (en) * | 2001-05-18 | 2005-12-29 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA) |
| US20030203384A1 (en) * | 2002-03-08 | 2003-10-30 | Chafin David R. | Multiplex detection of biological materials in a sample |
| US20030220844A1 (en) * | 2002-05-24 | 2003-11-27 | Marnellos Georgios E. | Method and system for purchasing genetic data |
| WO2004036188A2 (en) * | 2002-10-18 | 2004-04-29 | Cylene Pharmaceuticals, Inc. | Processes for identifying quadruplex-targeted antiviral molecules |
| EP2112229A3 (en) | 2002-11-25 | 2009-12-02 | Sequenom, Inc. | Methods for identifying risk of breast cancer and treatments thereof |
| US20050095627A1 (en) * | 2003-09-03 | 2005-05-05 | The Salk Institute For Biological Studies | Multiple antigen detection assays and reagents |
| EP1673478A4 (en) * | 2003-10-14 | 2007-08-22 | Cylene Pharmaceuticals Inc | COMPETITION TEST TO IDENTIFY QUADRUPLEX NUCLEIC ACID MODULATORS |
| US20090291437A1 (en) * | 2005-11-02 | 2009-11-26 | O'brien Sean | Methods for targeting quadruplex sequences |
| US8658608B2 (en) * | 2005-11-23 | 2014-02-25 | Yale University | Modified triple-helix forming oligonucleotides for targeted mutagenesis |
| US20100196336A1 (en) | 2006-05-23 | 2010-08-05 | Dongsu Park | Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods |
| JP2010515464A (ja) * | 2007-01-11 | 2010-05-13 | イエール・ユニバーシテイ | Ｈｉｖ細胞表面受容体の標的化不活性化のための組成物および方法 |
| US8097422B2 (en) | 2007-06-20 | 2012-01-17 | Salk Institute For Biological Studies | Kir channel modulators |
| EP2031059A1 (en) * | 2007-09-03 | 2009-03-04 | Karin Mölling | siDNA against hepatites C virus (HCV) |
| WO2009091934A1 (en) | 2008-01-17 | 2009-07-23 | Sequenom, Inc. | Single molecule nucleic acid sequence analysis processes and compositions |
| AU2009223671B2 (en) * | 2008-03-11 | 2014-11-27 | Sequenom, Inc. | Nucleic acid-based tests for prenatal gender determination |
| US8476013B2 (en) | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| US8962247B2 (en) * | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
| EP2391714B2 (en) | 2009-01-30 | 2019-07-24 | Whitehead Institute for Biomedical Research | Methods for ligation and uses thereof |
| US20100297127A1 (en) | 2009-04-08 | 2010-11-25 | Ghilardi Nico P | Use of il-27 antagonists to treat lupus |
| WO2011087760A2 (en) | 2009-12-22 | 2011-07-21 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
| WO2011133931A1 (en) | 2010-04-22 | 2011-10-27 | Genentech, Inc. | Use of il-27 antagonists for treating inflammatory bowel disease |
| US8877722B2 (en) | 2011-03-25 | 2014-11-04 | Idera Pharmaceuticals, Inc. | Compositions for inhibiting gene expression and uses thereof |
| CA2834218C (en) | 2011-04-29 | 2021-02-16 | Sequenom, Inc. | Quantification of a minority nucleic acid species using inhibitory oligonucleotides |
| ES2930180T3 (es) | 2012-03-02 | 2022-12-07 | Sequenom Inc | Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica |
| US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
| KR20150016336A (ko) | 2012-05-21 | 2015-02-11 | 더 스크립스 리서치 인스티튜트 | 리보솜 폴리뉴클레오티드 및 관련 발현 시스템 |
| CA2878979C (en) | 2012-07-13 | 2021-09-14 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
| WO2014168711A1 (en) | 2013-03-13 | 2014-10-16 | Sequenom, Inc. | Primers for dna methylation analysis |
| CN105814078A (zh) | 2013-10-11 | 2016-07-27 | 豪夫迈·罗氏有限公司 | Nsp4抑制剂及其使用方法 |
| EP3736344A1 (en) | 2014-03-13 | 2020-11-11 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US11136390B2 (en) | 2015-06-12 | 2021-10-05 | Alector Llc | Anti-CD33 antibodies and methods of use thereof |
| JP7497953B2 (ja) | 2015-06-12 | 2024-06-11 | アレクトル エルエルシー | 抗ｃｄ３３抗体及びその使用方法 |
| JP7525980B2 (ja) | 2015-08-28 | 2024-07-31 | アレクトル エルエルシー | 抗Ｓｉｇｌｅｃ－７抗体及びその使用方法 |
| ES2941968T3 (es) | 2015-10-01 | 2023-05-29 | The Whitehead Institute For Biomedical Res | Marcaje de anticuerpos |
| WO2017075432A2 (en) | 2015-10-29 | 2017-05-04 | Alector Llc | Anti-siglec-9 antibodies and methods of use thereof |
| JP2019508037A (ja) | 2016-02-16 | 2019-03-28 | イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ | 標的化遺伝子編集を増強するための組成物およびその使用方法 |
| US11147249B2 (en) | 2016-12-08 | 2021-10-19 | Alector Llc | Siglec transgenic mice and methods of use thereof |
| US11359014B2 (en) | 2017-05-16 | 2022-06-14 | Alector Llc | Anti-siglec-5 antibodies and methods of use thereof |
| CN117700548A (zh) | 2017-08-03 | 2024-03-15 | 艾利妥 | 抗cd33抗体及其使用方法 |
| US11470827B2 (en) | 2017-12-12 | 2022-10-18 | Alector Llc | Transgenic mice expressing human TREM proteins and methods of use thereof |
| EA202190183A1 (ru) | 2018-07-27 | 2021-05-18 | Алектор Ллс | Антитела к siglec-5 и способы их применения |
| WO2020061591A1 (en) | 2018-09-21 | 2020-03-26 | President And Fellows Of Harvard College | Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins |
| US20210381039A1 (en) | 2020-05-29 | 2021-12-09 | Front Range Biosciences, Inc. | Methods and compositions for pathogen detection in plants |
| US20230002779A1 (en) | 2020-06-29 | 2023-01-05 | Front Range Biosciences, Inc. | Characterization of plant cultivars based on terpene synthase gene profiles |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ209840A (en) * | 1983-10-17 | 1988-11-29 | Kaji Akira | A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action |
| US4876187A (en) * | 1985-12-05 | 1989-10-24 | Meiogenics, Inc. | Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences |
| US5107065A (en) * | 1986-03-28 | 1992-04-21 | Calgene, Inc. | Anti-sense regulation of gene expression in plant cells |
| US5194428A (en) * | 1986-05-23 | 1993-03-16 | Worcester Foundation For Experimental Biology | Inhibition of influenza virus replication by oligonucleotide phosphorothioates |
| US5015570A (en) * | 1988-05-13 | 1991-05-14 | Molecular Therapeutics, Inc. | Molecular diagnosis of Alzheimer Disease |
| JPH0655828B2 (ja) * | 1988-12-15 | 1994-07-27 | 信越化学工業株式会社 | 表面変性ポリメチルシルセスキオキサン球状微粒子及びその製造方法 |
| US5399676A (en) * | 1989-10-23 | 1995-03-21 | Gilead Sciences | Oligonucleotides with inverted polarity |
-
1994
- 1994-01-21 JP JP6517202A patent/JPH08505778A/ja active Pending
- 1994-01-21 CA CA002154358A patent/CA2154358A1/en not_active Abandoned
- 1994-01-21 WO PCT/US1994/000755 patent/WO1994017091A2/en not_active Application Discontinuation
- 1994-01-21 NZ NZ261976A patent/NZ261976A/en unknown
- 1994-01-21 CN CN94191214A patent/CN1122138A/zh active Pending
- 1994-01-21 AU AU61259/94A patent/AU684748B2/en not_active Expired - Fee Related
- 1994-01-21 EP EP94907851A patent/EP0680489A1/en not_active Withdrawn
-
1995
- 1995-04-06 US US08/418,123 patent/US5739308A/en not_active Expired - Lifetime
- 1995-07-20 FI FI953510A patent/FI953510A/fi not_active Application Discontinuation
- 1995-07-21 KR KR1019950703006A patent/KR960700263A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1994017091A2 (en) | 1994-08-04 |
| JPH08505778A (ja) | 1996-06-25 |
| EP0680489A1 (en) | 1995-11-08 |
| WO1994017091A3 (en) | 1994-09-15 |
| NZ261976A (en) | 1997-11-24 |
| FI953510A0 (fi) | 1995-07-20 |
| US5739308A (en) | 1998-04-14 |
| CN1122138A (zh) | 1996-05-08 |
| CA2154358A1 (en) | 1994-08-04 |
| AU6125994A (en) | 1994-08-15 |
| AU684748B2 (en) | 1998-01-08 |
| KR960700263A (ko) | 1996-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI953510A (fi) | Laskostuneita, tripleksiä muodostavia oligonukleotideja | |
| FI950715A0 (fi) | Ytmikromekanisk, symmetrisk tryckskillnadsgivare | |
| ATE257484T1 (de) | 6,9-verbrückte erythromycin-derivate | |
| DE69814441D1 (de) | 6,11-verbrückte erythromycinderivate | |
| ID21013A (id) | Deret nukleotida antipeka | |
| ITRM910890A1 (it) | Oligonucleotidi antisenso. | |
| NO960499L (no) | Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner | |
| FI972548A (fi) | Oligonukleotidi-dendrimeerikonjugaatit | |
| DE59502410D1 (de) | Mehrfachnocken | |
| DK0874814T3 (da) | 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler | |
| MA23595A1 (fr) | Oligonucleotides antisense | |
| FI1592U1 (fi) | Spruta, foeretraedesvis injektionsspruta | |
| ES1032571Y (es) | Gafa, | |
| ITRM920025A1 (it) | Oligonucleotidi antisenso chimicamente modificati. | |
| ITMI931785A0 (it) | Valilamidi di 7x-amino-1, 1-dioxo-cefem | |
| KR960028136U (ko) | 머리핀 | |
| KR940018847U (ko) | 머리핀 | |
| FI952416A0 (fi) | Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor | |
| FI950956A0 (fi) | Luftkabel, saosom haengspiralkabel | |
| KR960030542U (ko) | 팁, 담브 | |
| IT242729Y1 (it) | Agocannula per liposcultura, impugnabile con le dita | |
| KR970003994U (ko) | 머리핀 | |
| KR970003993U (ko) | 머리핀 | |
| KR970020578U (ko) | 머리핀 | |
| KR970007914U (ko) | 머리핀 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |